Back to search
FDAFDA · Food and drugs·Recall number D-0661-2020

Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.

Published January 22, 2020 · Recall initiated: January 7, 2020

Summary

FDA records drug Class II recall D-0661-2020, published January 22, 2020 and initiated January 7, 2020. Recalling firm: AVKARE Inc.; Status: Terminated; Reported quantity: 3,989 cartons; Lot: Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: High out of specification results for related compounds.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
AVKARE Inc.
Distributor
Nationwide in the USA.
Lot
Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13. recalled?

Yes. FDA published recall D-0661-2020 on January 22, 2020. Reported hazard: Failed Impurities/Degradation Specifications: High out of specification results for related compounds.

What should I do if I have this product?

Voluntary: Firm initiated · Letter